Huang Dennis Karl 4
4 · Ultragenyx Pharmaceutical Inc. · Filed May 10, 2021
Insider Transaction Report
Form 4
Huang Dennis Karl
See Remarks
Transactions
- Sale
Common Stock
2021-05-06$113.68/sh−363$41,266→ 40,506 total
Footnotes (3)
- [F1]Represents shares sold to pay required tax withholdings due to the vesting of RSUs.
- [F2]Includes 108 shares acquired under the Company's 2014 Employee Stock Purchase Plan on April 30, 2021.
- [F3]Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.